Following treatment with Allocetra–OTS, most of these inflammatory immune-modulators, including IL-6, IFN-γ, IL-10, TNFR1, IP-10, MCP-3, and IL-7, gradually decreased to normal levels with resolution of COVID-19. This evidence concerns the gene CXCL10 and COVID-19.